Broadwater Capital’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.6K Hold
100
– – 0.02% 127
2026
Q2
$21.6K Hold
100
– – 0.02% 132
2026
Q1
$17.6K Hold
100
– – 0.01% 136
2025
Q4
$17.6K Hold
100
– – 0.01% 136
2025
Q3
$14K Sell
100
-12,459
-99% -$1.68M 0.01% 148
2025
Q2
$12.6K Buy
12,559
+12,459
+12,459% +$1.55M 0.01% 152
2025
Q1
$13.7K Hold
100
– – 0.01% 146
2024
Q4
$15.3K Sell
100
-40
-29% -$6.75K 0.01% 148
2024
Q3
$27.1K Hold
140
– – 0.02% 133
2024
Q2
$32.5K Hold
140
– – 0.03% 128
2024
Q1
$30.2K Hold
140
– – 0.02% 132
2023
Q4
$36.2K Buy
+140
New +$34.4K 0.03% 127

Other funds holding BIIB

Broadwater Capital's BIIB Position: Q3 2026 in Review

Broadwater Capital held its Biogen (BIIB) position steady in Q3 2026 at 100 shares worth $22.6K. The position accounts for 0.02% of the portfolio, ranked #127.

Broadwater Capital first reported a position in BIIB in Q4 2023 and has held it in 12 quarters since. The position peaked at $36.2K in Q4 2023. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Broadwater Capital held 100 shares of Biogen worth $22.6K as of Q3 2026.
  • Broadwater Capital left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.02% of Broadwater Capital's portfolio in Q3 2026, its #127 holding.
  • Broadwater Capital first reported a position in Biogen in Q4 2023 and has held it in 12 quarters since.
  • Broadwater Capital's Biogen position peaked at $36.2K in Q4 2023.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Broadwater Capital's 13F filing for Q3 2026, filed 12 Nov 2026.